Assignee
ORAMED LTD
IL·8 granted patents·13 pending applications·36 citations·filing 2009–2025
Top patents by PatentIndex Score
21 records- 0196US11395848B2Methods and compositions for treating diabetesORAMED LTD·Filed 2020·Granted Jul 26, 2022·4 cites·20 claims
- 0292US11660327B2Methods and compositions for oral administration of proteinsORAMED LTD·Filed 2020·Granted May 30, 2023·2 cites·1 claims
- 0391US10967051B2Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereofORAMED LTD·Filed 2018·Granted Apr 6, 2021·3 cites·19 claims
- 0491US10881714B2Methods and compositions for oral administration of proteinsORAMED LTD·Filed 2018·Granted Jan 5, 2021·4 cites·29 claims
- 0587US10398762B2Methods and compositions for treating diabetesORAMED LTD·Filed 2013·Granted Sep 3, 2019·7 cites·23 claims
- 0686US10933022B2Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using sameORAMED LTD·Filed 2019·Granted Mar 2, 2021·3 cites·26 claims
- 0785US10350162B2Methods and compositions for oral administration of exenatideORAMED LTD·Filed 2013·Granted Jul 16, 2019·6 cites·11 claims
- 0885US2024299503A1Methods and Compositions for Treating DiabetesORAMED LTD·Filed 2023·Application pending·0 cites
- 0982US10342764B2Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using sameORAMED LTD·Filed 2013·Granted Jul 9, 2019·7 cites·46 claims
- 1082US2024181018A1Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae ThereofORAMED LTD·Filed 2023·Application pending·0 cites
- 1180US2023210956A1Methods and compositions for treating diabetesORAMED LTD·Filed 2022·Application pending·0 cites
- 1278US2024358647A1Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using SameORAMED LTD·Filed 2023·Application pending·0 cites
- 1376US2025387453A1Methods and Compositions for Treating DiabetesORAMED LTD·Filed 2025·Application pending·0 cites
- 1471US2022000986A1Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae ThereofORAMED LTD·Filed 2021·Application pending·0 cites
- 1571US2021322305A1Methods and Compositions for Oral Administration of ExenatideORAMED LTD·Filed 2021·Application pending·0 cites
- 1667US2019374615A1Methods and Compositions for Treating DiabetesORAMED LTD·Filed 2019·Application pending·0 cites
- 1766US2021369626A1Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using SameORAMED LTD·Filed 2021·Application pending·0 cites
- 1866US2011046053A1Methods and compositions for oral administration of exenatideORAMED LTD·Filed 2009·Application pending·0 cites
- 1962US2019314275A1Methods and Compositions for Rectal Administration of ExenatideORAMED LTD·Filed 2019·Application pending·0 cites
- 2060US2015335715A1Methods and compositions for treating nafld, hepatic steatosis, and sequelae thereofORAMED LTD·Filed 2014·Application pending·0 cites
- 2139US2021244806A1Recombinant Protease Inhibitor-Containing Compositions, Methods for Producing Same and Uses ThereofORAMED LTD·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →